Near future
No Result
View All Result
October 3, 2023
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+
Understand, anticipate, improve the future.
CES2023 / Coronavirus / Russia-Ukraine
Near future
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+

Understand, anticipate, improve the future.

No Result
View All Result
Medicine

BioNTech mRNA cancer vaccine begins Phase 2 clinical trials

Is it possible to beat cancer? BioNTech begins Phase 2 clinical trial for the cancer vaccine, hoping for positive results

December 22 2021
Gianluca RiccioGianluca Riccio
⚪ 4 minutes
Share105Pin25Tweet66SendShare18ShareShare13
clinical trials

READ IN:

Is it possible to cure cancer? The start of phase 2 of the "cancer vaccine" clinical trials of BionTech they make us hope that the answer is YES.

The famous German pharmaceutical company, responsible for the production of the Covid Pfizer vaccine, has been working for years on the creation of a vaccine intended to defeat cancer.

The first phase of the project has already been completed in 2019 (here the full news), and doctors have since had a chance to improve the definitive formula.

Pfizer vaccine trials with mRNA technology, has helped the developers tremendously, who are hoping to exploit the same element to slow the recurrence of the cancer.

The article continues after the related links

From the laboratory to life: here are the bacteria that "see" tumor DNA

TAU University, bacterial toxin causes cancer cells to "suicide".

Let's see what is happening and what are the chances of success of the project.

The start of a new trial

The BioNTech company was founded about 13 years ago, with the aim of developing functional cancer therapies.

The first goals were achieved in 2019, just before the pandemic intervened in the "general slowdown" of research. BioNTech was forced to focus on the vaccine, as well as many other pharmaceutical companies, trying to help the distressed population.

The elaboration of the Pfizer vaccine it has thus come down to us, bringing doctors closer to mRNA technology (which, however, they already used before).

Now that Pfizer production continues to flourish, the developers have returned to focus on the cancer problem. Phase two of the research clinical trial has officially begun, with the selection of a "candidate".

Colorectal cancer, has become the protagonist of BionNTech trials, given its high relapse rate.

The main goal of the new vaccine is to train our immune system to recognize cancer cells, so that they can attack them in time, eliminating them before they cause irreparable damage.

The synthesis cycle of an mRNA vaccine

How "tests" will work

Dr. Scott Kopetz, professor of gastrointestinal medical oncology at the University of Texas MD Anderson Cancer Center, is leading the phase 2 trial for testing the cancer vaccine.

Lately, he revealed a little more about the testing process and the number of participants admitted to the tests.

Kopetz manages the trial in the United States; other perpetrators follow cases in Germany, Spain and Belgium. The current number of participants it is about 200, but the idea is to increase them in the next few years.

The trail takes a long time to get a response that can be defined as "satisfactory".

Participants in the experiment will receive a vaccine injection every week for six weeks to build immune responses. After that, they will follow a biweekly schedule for about a year, with one dose every two weeks.

MRNA vaccines and the fight against cancer

The Covid-19 pandemic has led to a new rapprochement with the topic of mRNA vaccines.

Many doctors had - and still have - started experiments in this regard. The hope is to use this method to treat chronic diseases such as cancer and HIV.

Many people could take advantage of it, and return to live peacefully.

These new vaccines use a molecule called Messenger RNA (or mRNA for short). MRNA strands are small bits of genetic information that "teach" the body how to behave. Specifically, they help the immune system target a specific protein by exploiting information from the genetic material.

The spike protein has been the protagonist of Covid vaccines. After the trials, who knows how many other proteins could be attacked and how many diseases finally eradicated.

In the future, a substantial number of new mRNA vaccines are expected to arrive, which will try to defeat the most annoying problems of everyday life.

Tags: cancerm

Latest news

  • LK-99, new episode: is it really superconductive at room temperature?
  • Comment la CVP Impack Machine de Sparck Technologies peut Revolutionner l'Industrie de l'Emballage
  • Nobel Prize for Medicine to the creators of the mRNA techniques behind the Covid vaccines
  • SciMatch: take a selfie and meet your soulmate
  • The future glucose monitoring? A new, ingenious sweat sensor
  • From death to passion: if spider venom overcomes erectile dysfunction
  • Getting old? No, thanks: the future of longevity between research and speculation
  • Videogames and photorealism: increasingly thin border between game and reality
  • This is how a war between humans and artificial intelligence would end
  • The alarm of Japanese scientists: microplastics also in the clouds


GPT Chat Megaeasy!

Concrete guide for those approaching this artificial intelligence tool, also designed for the school world: many examples of applications, usage indications and ready-to-use instructions for training and interrogating Chat GPT.

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff

Enter the Telegram channel of Futuroprossimo, click here. Or follow us on Instagram, Facebook, Twitter, Mastodon e LinkedIn.

FacebookTwitterInstagramTelegramLinkedInMastodonPinterestTikTok

The daily tomorrow.


Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

  • Environment
  • Architecture
  • Artificial intelligence
  • Gadgets
  • concepts
  • Design
  • Medicine
  • Spazio
  • Robotica
  • Work
  • Transports
  • Energy
  • Edition Francaise
  • Deutsche Ausgabe
  • Japanese version
  • English Edition
  • Portuguese Edition
  • Read more
  • Spanish edition

Subscribe to our newsletter

  • The Editor
  • Advertising on FP
  • Privacy Policy

© 2023 Near future - Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.

No Result
View All Result
Understand, anticipate, improve the future.
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+